Expert insights. Personalized for you.
Biotechnology Related Topics 
Bill Of Health
NOVEMBER 12, 2021
Biotechnology Intellectual Property Matt Bauer Research Funding patents universitiesBy Matt Bauer. In academia, many of the scientists who are recognized as inventors on patents see little economic gain from these agreements.
Bill Of Health
OCTOBER 29, 2021
By Tlaleng Mofokeng, Daniel Wainstock, and Renzo Guinto. In recent years, there have been growing calls to “ decolonize ” the field of global health.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bill Of Health
OCTOBER 15, 2021
By Ellen ‘t Hoen. The COVID-19 pandemic has laid bare the lack of regulation for the sharing of intellectual property (IP) and technology needed for an effective and equitable response to the crisis.
Bill Of Health
OCTOBER 13, 2021
By Ana Santos Rutschman. The COVID-19 pandemic has brought into sharp relief longstanding equity problems surrounding the allocation of newly developed vaccines against emerging pathogens.
Bill Of Health
DECEMBER 8, 2021
Biotechnology Health Law Policy International Pharmaceuticals Public Health Research Funding Resource Allocation Vaccines COVID covid boosters covid pandemic infectious disease infectious disease surveillance mers pandemic preparedness pandemic prevention pandemic response sars SARS-CoV-2
Bill of Health
APRIL 14, 2022
Animal Research Biotechnology FDA Health Law Policy Organs Public Health Resource Allocation Organ Transplantation organ transplants xenotransplantationBy Jacob Balamut.
Bill of Health
JANUARY 6, 2022
Biotechnology Featured Genetics Health Information Technology History Intellectual Property Jorge Contreras Research Funding Scientific Evidence Supreme Court Vaccines aclu Association for Molecular Pathology v. By Jorge L. Contreras.
Bill of Health
APRIL 6, 2022
By Cynthia M.
Bill of Health
FEBRUARY 18, 2022
Biotechnology Health Law Policy Intellectual Property Matt Bauer biologics Biosimilars patents Trade SecretsBy Matt Bauer.
Bill of Health
APRIL 15, 2022
Biotechnology CRISPR Matt Bauer Medical devices Public Health COVID-19 diagnostic tests Diagnostics mCARMEN pandemic pandemic diagnostics pcr rapid antigen testsBy Matthew Bauer and Nicole Welch. Diagnostic tests have changed in the eyes of many Americans across the COVID-19 pandemic.
Bill of Health
MARCH 24, 2022
At the research and development (R&D) stage, government funders can bind producers to equity goals through targeted contractual provisions, as we explain in a recently-published Nature Biotechnology article. By Sapna Kumar and Ana Santos Rutschman.
Bill Of Health
NOVEMBER 16, 2021
Announcements Bioethics Biotechnology Call for Abstracts Health Law Policy Petrie-Flom Center Public Health Publications Journal of Law and the Biosciences The Journal of Law and the BiosciencesAmerican law on reproduction seems likely to change, perhaps radically, in 2022, as the U.S.
Bill Of Health
AUGUST 12, 2021
By Brook K. Baker .
Bill Of Health
OCTOBER 19, 2021
Myriad Genetics that naturally occurring DNA sequences are not patentable, a ruling that has had repercussions throughout the scientific community and the biotechnology industry. Register now for tomorrow’s discussion of The Genome Defense ! By Jorge L. Contreras.
Bill of Health
JANUARY 21, 2022
Announcements Bioethics Biotechnology Call for Abstracts Health Law Policy Petrie-Flom Center Public Health Publications Journal of Law and the Biosciences The Journal of Law and the BiosciencesAmerican law on reproduction seems likely to change, perhaps radically, in 2022, as the U.S.
HIT Consultant
NOVEMBER 18, 2021
Benchling’s growth is fueled by the rapid rise of biotechnology , one of the world’s fastest-growing industries. Biotechnology is rewriting life as we know it.
HIT Consultant
JANUARY 3, 2022
HCS), a company focused on helping patients adhere to and benefit from pharmaceutical and biotechnology products. What You Should Know: – Strategic acquisition of leading patient adherence technology and services provider to complement CareMetx current suite of patient access products.
HIT Consultant
MARCH 30, 2022
VivoSense interprets and contextualizes data gathered directly from the patient and makes it available to clinical researchers in pharma and biotechnology.
HIT Consultant
OCTOBER 7, 2021
The firm is continuing to add new pharmaceutical and biotechnology companies to its client base, in new therapeutic areas, and has continued to expand with the addition of over 100 new employees so far in 2021.
Bill Of Health
SEPTEMBER 8, 2021
The Health Law, Policy, Bioethics, and Biotechnology Workshop provides a forum for discussion of new scholarship in these fields from the world’s leading experts.
Bill Of Health
SEPTEMBER 21, 2021
These six students are a fantastic cohort of health law policy, biotechnology, and bioethics scholars who join us from across Harvard. (Clockwise from top left: Matt Bauer, Jack Becker, Bailey Kennedy, Cathy Zhang, Leah Pierson, Kaitlynn Milvert).
Bill of Health
MARCH 1, 2022
Potentially the most relevant case for teaching students about IP is that they may want to leverage this knowledge to turn their laboratory discoveries into new biotechnology companies. By Matt Bauer.
Perficient Digital Transformation
MAY 19, 2022
Of these unicorns, 80 fall into the category of healthcare and biotechnology. Let’s talk about unicorns. What do unicorns have to do with business? According to Investopedia, a unicorn is an organization that has a valuation of more than $1 billion.
Bill Of Health
AUGUST 18, 2021
She previously served as a Research Fellow in Medicine, Artificial Intelligence, and Law at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School for the Project on Precision Medicine, Artificial Intelligence, and the Law ( PMAIL ).
HIT Consultant
AUGUST 30, 2021
What You Should Know: Fresenius Medical Care (FMC) today announced its plans to invest an additional $25 million in clinical-stage biotechnology platform company Humacyte following the extension of its collaboration in June.
Bill of Health
APRIL 26, 2022
To navigate the myriad interests and stakes involved in creating federal psychedelic policy, the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School convened a virtual panel discussion with three leading psychedelic policy advocates. By James R. Jolin.
HIT Consultant
JANUARY 11, 2022
What You Should Know: – PostEra , a biotechnology company specializing in machine learning for preclinical drug discovery, today announced $24M in equity financing to accelerate medicinal chemistry and bring new cures to patients.
GoMoHealth
DECEMBER 9, 2021
NEWS RELEASE. November 15, 2021. Contact: Shelley R. Schoenfeld, Chief Marketing Officer. Ph: 732-484-9144. Email: sschoenfeld@gomohealth.com. GoMo Health Acquires Trajectory, a Specialist Health and Wellness Agency.
Bill Of Health
SEPTEMBER 22, 2021
The Health Law, Policy, Bioethics, and Biotechnology Workshop provides a forum for discussion of new scholarship in these fields from the world’s leading experts.
HIT Consultant
JANUARY 14, 2022
Verana Health is the exclusive data partner of the American Academy of Ophthalmology, American Urological Association, and American Academy of Neurology and collaborates with multinational pharmaceutical companies as well as emerging biotechnology and biopharmaceutical companies.
Bill Of Health
SEPTEMBER 29, 2021
The Health Law, Policy, Bioethics, and Biotechnology Workshop provides a forum for discussion of new scholarship in these fields from the world’s leading experts.
Cloud Blogs
MAY 18, 2021
Adaptive Biotechnologies is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. When communities have access to better data, they can make better decisions.
Perficient Digital Transformation
MARCH 22, 2022
In the previous part of this series, we discussed how enterprise search can accelerate innovation with a single source of truth. In this part, we will explore the fifth and final way to address information overload with AI-powered search: personalize interactions in the moments that matter.
HIT Consultant
JANUARY 28, 2022
Benchling , pioneer of the R&D Cloud powering the biotechnology industry appoints Paul Robson, a cloud veteran as President of Field Operations and Elena Donio, the former CEO of Axiom and President of Concur, to its board, as a director and compensation committee chair. Michael Cantor.
Perficient Digital Transformation
FEBRUARY 22, 2022
Do you spend hours each month searching for, but not always finding, the information you need to do your job? These are often not just ‘like-to-have’ files, but rather those that you actually need to complete your work.
203 
Let's personalize your content